Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
CSTM enters its October 21 earnings call with a notable shift underway in short positioning. Shorts have been covering steadily while a new analyst initiates coverage and the stock sits 27% below where insiders were selling earlier this year.
Short interest has dropped sharply in the past week. Bears have covered roughly 900,000 shares since October 7, pulling the position down 13.5% in seven days to 4.5% of the free float. The month-on-month decline is also meaningful at close to 10%. What has not changed is the lending market: borrow availability is effectively unlimited, with more than 134 million shares available for loan against a short position of just over 6 million. Cost to borrow is cheap at 0.55% and has been under 1% all year. This is not a setup where covering was forced. It looks like discretionary de-risking ahead of the print.
Options positioning tells a similar story of relaxed sentiment. The put/call ratio is running at 0.42, just barely above its 20-day average and well below the 52-week high of 1.39. Call open interest comfortably outpaces puts. Nothing in the options market points to traders bracing for a miss on October 21. The ORTEX short score has also eased, dropping from around 42 two weeks ago to 39 now, reflecting the softer short positioning.
The Street is broadly constructive but has been trimming targets. Barclays initiated coverage on October 14 with an Equal-Weight rating and a $28 target, a cautious starting point relative to the $25.77 close. UBS and Deutsche Bank both maintained Buy ratings last week while cutting targets: UBS moved from $34 to $32, Deutsche Bank from $39 to $36. Wells Fargo has held its Overweight but edged its target down from $39 to $38 last month. The consensus sits at Hold with a mean target near $30, implying about 16% upside from current levels. Valuation remains genuinely cheap by one measure: EV/EBITDA is around 5.7x and the EV/EBIT factor ranks in the 87th percentile versus the broader universe. The PE of 8.2x does not look stretched for a company where earnings momentum has been soft, with the 30-day and 90-day EPS revision scores in the bottom fifth of the market.
There is an activist dimension worth watching. Caisse des Depots (CDC), the French state investment group and Constellium's largest effective shareholder via its Bpifrance vehicle, filed a Schedule 13D/A in May 2026 declaring a 6.2% stake. A 13D filing signals active intent rather than passive ownership, and this is the most structurally significant holder on the register. Stakes are as-last-disclosed around the 5% threshold, so the position may have moved since the filing. BlackRock has also increased its stake slightly, recently reported at 9.4% of shares. American Century is the most recent active builder among institutional names, adding over 2.1 million shares in the quarter to September 30. On the insider side, the 90-day net is negative: sales of around $2.9 million in net value since early August, though the only buy in the period was a small open-market purchase by director Jean-Christophe Deslarzes at $27.24 on August 3. Insiders were heavier sellers in May when the stock was trading above $33.
Wikipedia traffic is running 3.4 standard deviations above its own 90-day history, a notable spike in retail attention heading into earnings. This measures attention, not a revenue signal, but it reflects the print is on people's radar.
Peer metals names have had a mixed week. TX and CLF both rose more than 3% and 5% respectively on the week, outrunning CSTM's 1.1% gain. AA was the laggard, down nearly 4% on the week. The one prior earnings reaction in the data shows CSTM fell 1.75% on the day of its July 29 result before recovering 2% over the following five days. With shorts retreating and options relaxed, the balance of pre-earnings positioning points away from a defensive setup, making next Tuesday's print the key test of whether the Street's trimmed-but-still-bullish targets find fundamental support.
See the live data behind this article on ORTEX.
Open CSTM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
